Mayo Clinic Laboratory and pathology research roundup: August 17
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19. Via PubMed
Published to PubMed This Week
- Genetic insights into biological mechanisms governing human ovarian ageing.
- Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.
- Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a consensus document of the ESC working group on cellular biology of the heart and European association of percutaneous cardiovascular interventions (EAPCI).
European Heart Journal
- Exercise-induced angiogenesis is dependent on metabolically primed ATF3/4+ endothelial cells.
- Cell fate conversion prediction by group sparse optimization method utilizing single-cell and bulk OMICs data.
Briefings in Bioinformatics
- A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.
- Assessment of opioid use and analgesic requirements after endoscopic sinus surgery: A randomized clinical trial.
JAMA Otolaryngol Head and Neck Surgery
- The need for dedicated microbiology leadership in the clinical microbiology laboratory.
Journal of Clinical Microbiology
- Fisetin for COVID-19 in skilled nursing facilities (COVID-FIS): senolytic trials in the COVID era.
Journal of The American Geriatrics Society
- Aneurysmal bone cyst with an unusual clinical presentation and a novel VDR-USP6 fusion.
Genes, Chromosomes and Cancer